PortfoliosLab logo
Omnicell, Inc. (OMCL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US68213N1090

CUSIP

68213N109

IPO Date

Aug 7, 2001

Highlights

Market Cap

$1.47B

EPS (TTM)

$0.27

PE Ratio

116.22

PEG Ratio

2.28

Total Revenue (TTM)

$866.09M

Gross Profit (TTM)

$378.38M

EBITDA (TTM)

$67.20M

Year Range

$22.66 - $55.75

Target Price

$50.71

Short %

7.35%

Short Ratio

3.62

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Omnicell, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


150.00%200.00%250.00%300.00%350.00%400.00%December2025FebruaryMarchAprilMay
166.98%
370.27%
OMCL (Omnicell, Inc.)
Benchmark (^GSPC)

Returns By Period

Omnicell, Inc. (OMCL) returned -42.97% year-to-date (YTD) and -15.25% over the past 12 months. Over the past 10 years, OMCL returned -3.01% annually, underperforming the S&P 500 benchmark at 10.43%.


OMCL

YTD

-42.97%

1M

-16.81%

6M

-51.60%

1Y

-15.25%

5Y*

-18.00%

10Y*

-3.01%

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of OMCL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20251.06%-15.40%-8.15%-10.58%-18.78%-42.97%
2024-14.51%-18.43%11.39%-8.28%21.56%-16.94%7.91%52.28%-1.98%11.56%-4.21%-4.44%18.31%
202310.02%-1.86%7.77%3.58%20.82%0.34%-14.28%-9.96%-20.79%-21.09%-6.13%12.80%-25.37%
2022-16.79%-13.89%0.16%-15.69%1.82%2.33%-3.19%-7.11%-14.92%-11.16%-33.25%-2.31%-72.06%
2021-1.85%7.72%2.34%11.67%-4.15%8.96%-3.27%5.99%-4.41%20.02%-0.65%1.94%50.34%
2020-0.54%0.23%-19.50%11.16%-8.22%5.54%-0.47%-5.14%11.97%15.93%21.14%14.47%46.87%
20196.35%30.43%-4.84%-0.59%-1.13%8.28%-12.58%-4.53%0.65%-2.60%13.64%2.16%33.44%
20181.13%-11.01%-0.57%-0.69%8.00%12.67%13.44%15.55%4.58%-1.67%9.24%-20.70%26.27%
20175.90%5.92%6.90%1.85%-3.62%8.02%15.08%3.43%-0.49%-2.45%5.22%-7.44%43.07%
2016-9.94%-2.22%1.83%14.32%1.54%5.81%13.00%-2.84%1.92%-14.82%9.89%-5.44%9.07%
2015-3.89%10.12%0.14%1.23%4.08%1.97%-3.16%-6.96%-8.48%-12.54%10.88%3.05%-6.16%
20141.14%11.46%-0.56%-7.48%0.19%8.22%-4.56%2.74%-2.91%18.22%-0.34%2.86%29.73%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of OMCL is 38, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of OMCL is 3838
Overall Rank
The Sharpe Ratio Rank of OMCL is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of OMCL is 3838
Sortino Ratio Rank
The Omega Ratio Rank of OMCL is 3838
Omega Ratio Rank
The Calmar Ratio Rank of OMCL is 4141
Calmar Ratio Rank
The Martin Ratio Rank of OMCL is 3636
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Omnicell, Inc. (OMCL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Omnicell, Inc. Sharpe ratios as of May 9, 2025 (values are recalculated daily):

  • 1-Year: -0.24
  • 5-Year: -0.38
  • 10-Year: -0.07
  • All Time: 0.08

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Omnicell, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
-0.24
0.48
OMCL (Omnicell, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Omnicell, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-86.17%
-7.82%
OMCL (Omnicell, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Omnicell, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Omnicell, Inc. was 86.67%, occurring on Oct 8, 2002. Recovery took 195 trading sessions.

The current Omnicell, Inc. drawdown is 86.17%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-86.67%Dec 6, 2001211Oct 8, 2002195Jul 18, 2003406
-86.59%Nov 24, 2021865May 7, 2025
-77.96%Oct 3, 2007356Mar 3, 20091428Oct 31, 20141784
-72.92%Mar 5, 2004301May 13, 2005489Apr 25, 2007790
-42.27%Sep 7, 20017Sep 21, 200152Dec 5, 200159

Volatility

Volatility Chart

The current Omnicell, Inc. volatility is 20.83%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%December2025FebruaryMarchAprilMay
20.83%
11.21%
OMCL (Omnicell, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Omnicell, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Omnicell, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 2.8% positive surprise.


-0.200.000.200.400.600.801.0020212022202320242025
-0.15
0.58
Actual
Estimate

Valuation

The Valuation section provides an overview of how Omnicell, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for OMCL, comparing it with other companies in the Health Information Services industry. Currently, OMCL has a P/E ratio of 116.2. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for OMCL compared to other companies in the Health Information Services industry. OMCL currently has a PEG ratio of 2.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for OMCL relative to other companies in the Health Information Services industry. Currently, OMCL has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for OMCL in comparison with other companies in the Health Information Services industry. Currently, OMCL has a P/B value of 1.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items